{
  "created_at": "Sat Dec 18 10:33:38 +0000 2021",
  "id_str": "1472095831771820036",
  "full_text": "In Britain a two-dose course of the Pfizer or AstraZeneca vaccine was, at most, 20% effective against infection by Omicron, researchers found. But boosters can make a big difference https://t.co/siq6MSv0mU",
  "display_text_range": [
    0,
    205
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/siq6MSv0mU",
        "expanded_url": "https://econ.st/3IZAq96",
        "display_url": "econ.st/3IZAq96",
        "indices": [
          182,
          205
        ]
      }
    ]
  },
  "user": {
    "name": "The Economist",
    "screen_name": "TheEconomist",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-_normal.jpg"
  },
  "retweet_count": 34,
  "favorite_count": 83,
  "possibly_sensitive": false,
  "original_created_at": "Sat Dec 18 06:46:11 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "英国では、ファイザー社またはアストラゼネカ社のワクチンを2回接種しても、オミクロンへの感染に対する効果はせいぜい20％であることが判明した。しかし、ブースターは大きな違いを生むことができる https://t.co/siq6MSv0mU"
    },
    {
      "locale": "zh",
      "full_text": "研究人员发现，在英国，两剂量的辉瑞或阿斯利康疫苗最多只能对Omicron的感染产生20%的效果。但是增强剂可以带来很大的不同 https://t.co/siq6MSv0mU"
    },
    {
      "locale": "zh-Hant",
      "full_text": "研究人員發現，在英國，兩劑量的輝瑞或阿斯利康疫苗最多隻能對Omicron的感染產生20%的效果。但是增強劑可以帶來很大的不同 https://t.co/siq6MSv0mU"
    }
  ]
}